An indirect method for the determination of silicon in blood samples has been developed. The proposed method overcame interference from a large amount of salts and phosphate in blood samples, and enabled us to determine the silicon contents in serum and whole blood by the same operation. After blood samples were digested by microwave heating, silicon, present as silicate in the sample solution, was reacted with molybdate to form a silicomolybdate complex. The complex was then separated from unreacted molybdate by a cation-exchange resin column. The molybdate liberated from the complex was spectrophotometrically determined in place of silicon. Since the method is not affected the composition of matrices between serum and whole blood, it could achieve good precision and accuracy, and could also estimate the silicon contents in erythrocytes from those in serum and whole blood. The sensitivity of the method was almost equal to that of the conventional silicomolybdenum blue method, and the calibration curve was linear up to 50 µmol l -1 of silicon with a detection limit of 1.1 µmol l -1 in whole blood. The mean concentrations of silicon in five healthy subjects were 11 µmol l -1 for serum, 28 µmol l -1 for whole blood and 50 µmol l -1 for erythrocytes. Thus, the obtained distribution ratio between serum and erythrocytes was in the range of 0.15 -0.39, and was found to be included in a narrow range.
Introduction
Silicon is a ubiquitous element in the environment as the major component of rocks, whereas it is only found in small quantity in the body of organisms, 1 and is regarded as a trace element. For rat 2 and chicken, 3 silicon has been proved to be an essential element related to collagenous connective tissue formation and the growth of bone by a silicon defficiency experiment. In the case of human, however, evidences to prove the essentiality of silicon are still insufficient. Although in human serum silicon is supposed to be adsorbed on the surface of some sorts of proteins, 4 the chemical species and the distribution of silicon in blood have also been obscure.
On the other hand, an interesting relevance between silicon and aluminum has been reported. 1, 5 The serious toxicity of aluminum has been widely recognized since an aluminumcontaminated dialysis fluid was used for renal-failure patients, which resulted in dialysis encephalopathy, anaemia and bone disorder. [6] [7] [8] Because silicon is apt to interact with aluminum and to be a hydroxyaluminosilicate, it is supposed to decrease the toxicity of aluminum by promoting to inhibit absorption from the gastrointestinal tract and to be excreted from urine. In order to clarify the further roles of silicon in the body and its relevance to disease, a reliable method for the determination of silicon in biological samples, especially blood, has been demanded.
Graphite furnace atomic absorption spectroscopy (GF-AAS), [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] inductively coupled plasma atomic emission spectroscopy (ICP-AES), 19 direct current plasma atomic emission spectroscopy (DCP-AES) 20 and spectrophotometry 21 have been used for the determination of silicon in blood samples. However, the determination of a small amount of silicon in blood is often interfered due to the complicated composition of organic and inorganic matrices. In recent years, GF-AAS has been the most popular because of its high sensitivity and simple operation, although it has some drawbacks of decreasing the analytical signal caused by forming refractory carbides, and a strong influence of the matrix component. Therefore, it is necessary to use with appropriate correction, such as a matrix modifier 18 and molybdenum-coated tubes and platforms. 15 ICP-AES and DCP-AES also have the conventional problems of clogging on the nebulizer and deposition on the torch, because a blood sample is viscous and has a high solid content. 22, 23 Regarding the spectrophotometric method, a silicomolybdenum yellow or blue method based on the reaction of silicon, present as silicate in an aquatic solution, with molybdate has been used. However, in the case that this method is applied for biological samples, a large amount of phosphate 21 and various salts 24, 25 interfere seriously. An error from phosphate is caused because it reacts with molybdate and yields yellow or blue phosphomolybdate, similarly to silicate. However, the error from the salts (so-called salt error) has been explained as follows: the analytical conditions and parameters have been optimized so that the β -isomer of the silicomolybdate complex forms more preferentially than the α -isomer. 26 In saline water containing a large amount of salts, such as NaCl or MgCl2, however, the formation of the β -isomer is accompanied by that of the α -isomer, which has a lower light absorptivity. As a consequence, an erroneously low absorbance is measured, depending on the salt concentration, even at a constant amount of silicate. To correct for the salt error, it is generally recommended to use a calibration curve prepared with a NaCl solution having the same ionic strength as samples. However, in the case of blood, which has a complicated salt composition, it is difficult to estimate or correct the salt error.
As an alternative spectrophotometric method for silicate, an indirect approach has been proposed. The principal of an indirect method is based on the following three steps: (1) Silicate in the sample is reacted with reagent molybdate to turn into a silicomolybdate complex. (2) The complex (including both α -and β -complexes) is quantitatively separated from the unreacted, excess reagent molybdate. (3) The molybdate containing the complex is determined. The advantages of the indirect method are that the salt error caused by the isomers can be eliminated, since the molybdate is determined instead of silicate and, moreover, by employing specific separation for the silicomolybdate, interference from phosphate, which has a similar reactivity with silicate, can also be prevented. Thus, owing to being free from the interferences of various components in blood samples, the reliability of the measurement can be improved in both precision and accuracy. In addition, the indirect method implies a sensitive determination, because it is based on the determination of a twelve-fold stoichiometric amount of molybdate against silicate.
Some indirect methods have, so far, been proposed utilizing solvent extraction by diethyl ether or n-pentanol for the separation step. The measurements for molybdate in the organic extracts were made by using atomic absorption spectroscopy, [27] [28] [29] polarography, 30 and spectrophotometry as molybdatecomplexes with dyes 31, 32 or as peroxymolybdic acid by a reaction with H2O2. 33 In this study, a cation-exchange resin column was employed for the quantitative separation of a silicomolybdate complex. This method allows the operation to be simple compared with that using solvent extraction, and is entirely free from interferences from a large amount of salts and phosphate in blood samples.
From a comparison among the Bromopyrogallol Red (BPR) method, 34 the flavon-3-ol-2′-sulfonate (FS) method 35 and the Tiron method 36 for the determination of molybdate, FS method was found to be appropriate, and could be determined in the range of 1.1 -50 µmol l -1 of silicon with a sensitivity equal to that of the conventional silicomolybdenum blue method.
Since the proposed method was superior in precision and accuracy, and could be applied for both serum and whole blood samples by the same operation, it enabled us to estimate the silicon concentration in erythrocytes from the values in serum and whole blood. The fractional determination of blood sample was performed for healthy individuals, and the normal levels of silicon in serum, whole blood and erythrocytes were obtained. From these results, the distribution ratio of silicon between serum and erythrocytes was also obtained. The proposed distribution ratio in this study is expected to be a new index to monitor the balance of trace elements in the body.
Experimental

Reagents
Sodium molybdate dihydrate, perchloric acid and sodium hydroxide were obtained from Wako Pure Chemical Industries (Osaka, Japan). Analytical reagent-grade sodium flavon-3-ol-2′-sulfonate (FS) was obtained from Tokyo Kasei (Tokyo, Japan). All other reagents used were of reagent grade.
Standard solutions
Stock standard solutions of the respective metals were purchased or prepared by the following procedure and diluted appropriately for use. All chemicals were of analytical grade, unless otherwise indicated, and purchased from Wako. 1200 mg l -1 SiO2 and GeO2 standard solutions: Quartz wool and GeO2 (purity: 99.99%) were dried at 110˚C for 12 h. Each 0.6000 g of them was fused with 12 g of sodium carbonate; the resulting cake was dissolved with deionized water up to 500 ml. 1000 mg l -1 Mo and P standard solutions: 0.2420 g of sodium molybdate dihydrate, or 0.1361 g of potassium dihydrogen orthophosphate, was dissolved in 100 ml of deionized water, respectively. 1000 mg l -1 As(V) standard solution: 1 ml of 1000 mg l -1 As(III) standard solution obtained from commercial source was heated overnight with 1 ml of perchloric acid on a hot plate. The solution was dried once and the residue was dissolved in 1 ml of 0.1 mol l -1 HNO3. 1000 mg l -1 V(V), Cr(VI), W standard solutions were obtained from a commercial source.
Apparatus
The decomposition of blood samples was performed with a microwave digestion apparatus (Anton Parr, Graz, Austria) and attached teflon-lined pressure vessels (HF-50 type). The absorbance was measured by using a UV-VIS recording spectrophotometer (Hitachi, Tokyo, Japan) with a 10 mm pathlength quartz cell. The separation column used was prepared by packing a water-swelled cation-exchange resin (Dowex 500W × 8, 100 -200 mesh, H + -form, Dow Chemicals, USA) in a glass column (10 mm i.d. × 200 mm) to a height of 150 mm.
Sample collection and microwave digestion
Approx. 5 ml of blood was taken from a healthy subject with a polyethylene syringe, which was immediately weighed on a balance; 1.0 g (for whole blood sample) and 3.0 g (for serum sample) portions of the blood were transferred into a teflon digestion vessel and a teflon centrifuge tube, respectively. The latter was left for about 1 h to clot at room temperature. After clotted blood was centrifuged for 15 min at 1500g, 1.0 g of serum was taken from supernatant into a teflon digestion vessel. To each digestion vessel, 5 ml of 70% nitric acid and 1 ml of 35% hydrochloric acid were added. Samples were digested on a microwave digestion apparatus according to following program: 100 -600 W, 5 min; 600 -600 W, 5 min; 1000 -1000 W, 50 min. Furthermore, to decompose the organic residue, each sample solution was transferred to a capped 30-ml teflon beaker and heated with 1 ml of perchloric acid on a hot plate at 200˚C for 6 h. After the digestate was dried completely, the residue was dissolved in 1 ml of 0.1 mol l -1 HCl and stored as a stock sample solution. For the determination of silicon, the stock sample solution was diluted with deionized water to ten-fold for a whole blood or four-fold for a serum sample.
Standard procedure
Each 0.1-ml aliquot of a 0.5 mol l -1 molybdate reagent and 2.4 mol l -1 HCl was admixed with a 2-ml sample, and the mixture was allowed to stand for 15 min. A 2-ml portion of the mixture was loaded on the top of a cation-exchange column, and then the silicomolybdate complex was eluted by passing 8 ml of deionized water into a 10-ml volumetric flask. To the flask, 0.1 ml of a 4 mol l -1 NaOH solution was added and mixed well in order to liberate molybdate from the complex. A 2-ml portion of the solution was transferred into a 10-ml polyethylene test tube and mixed with 1 ml of 1.5 mol l -1 perchloric acid and 0.8 1292 ANALYTICAL SCIENCES SEPTEMBER 2003, VOL. 19 ml of 2 × 10 -2 mol l -1 FS solution. After being allowed to stand for 5 min, the absorbance was measured at 370 nm against the calibration curve of molybdenum, which was prepared by adding the same amount of NaOH as the blood samples.
From the molybdenum concentrations, the silicon concentrations were calculated as follows: Si (µmol l -1 ) = (5/12.0) (2.2/2.0) Mo found (µmol l -1 ).
Results and Discussion
Effect of salt on the conventional silicomolybdenum yellow and blue methods
To examine the effect of salt on the molybdenum yellow and blue methods, the following experiment was performed using seawater, which included a similar composition of salts to human serum. A known amount of silicate standard solution was added to deionized water, 50% diluted seawater and neat seawater, and then reacted with molybdate. The amount of silicomolybdate yellow complex formed was monitored as the change in the absorbance against the elapsed reaction time (Fig.  1) . Curve 1, in the absence of sea salt, shows that the absorbance increased rapidly and reached a maximum plateau at 5 min. According to Strickland, 26 at the plateau, the β -complex is predominantly formed.
After 15 min, the absorbance gradually decreased.
The decrease in the absorbance is attributed to the so-called β -to -α conversion. 26, 37 Curves 2 and 3 show the changes in the absorbance in the presence of sea salt, and their plateaus appeared at 15% and 17% lower levels than in curve 1, respectively. This can be attributed to the fact that the formation of the β -complex was incomplete, and accompanied by the formation of the α -complex, depending on the concentration of sea salt. Thus, the presence of salt affected not only the conversive rate 38 of β -to -α conversion (t > 15 min), but also the formation ratio of the β -to α -complex (5 < t < 15 min). Since the light absorptivities of α -and β -complexes also differ in their reduced blue forms, the salt error is observed similarly in the silicomolybdenum blue method.
Separation of silicomolybdate complex from unreacted, excess molybdate
The reaction mixture, including a known amount of silicate and reagent molybdate, was loaded on a cation-exchange column and then eluted with deionized water. Curve 1 in Fig. 2 shows a chromatogram of silicomolybdate complex and excess reagent molybdate.
Since the negatively-charged silicomolybdate complex interacts only little with the cationexchange resin, the complex eluted quantitatively by the first 10 ml fraction, while the excess unreacted molybdate eluted after a 15 ml fraction, because the unreacted molybdate formed positively-charged species, such as [Mo2O5(OH)(H2O)5] + and [Mo2O5(H2O)6] 2+ , 39 under the strongly acidic conditions provided by the resin in the H + -form. Thus, it is found that the separation of silicomolybdate complex was successfully achieved by collecting the first 10 ml fraction of the eluent.
Time needed for the quantitative formation of a silicomolybdate complex
From Fig. 1 , reaction time needed for a quantitative formation of the α and β -silicomolybdate complex, indicated by the time that the curves reached to the maximum, is 5 min in the absence of salt (curve 1) and 10 min in neat seawater (curve 3). After that, though β -to -α conversion proceeds gradually, this influence can be neglected, since there is no discrimination between the α -and β -complex in the indirect method. Therefore, it was found that the reaction time is sufficiently more than 10 min, even when including salts. Moreover, while changing the reaction time, the silicate solutions in water and seawater described above were analyzed according to the standard procedure. The found silicate concentration was consistent with the added amount of silicon at reaction times ranging from 10 min to 24 h. The formed complex was stable for a long time.
Liberation of molybdate from the silicomolybdate complex by the addition of sodium hydroxide
After a 20 µmol l -1 silicate standard solution was reacted with molybdate, and a column treatment, the amount of molybdate in the eluent from the column was analyzed by the FS method. The found silicate concentration was 9.0 µmol l -1 , lower than the original value. This seemed to be due to an incomplete liberation of molybdate from the complex. Therefore, before the determination of molybdate, the complex must be decomposed. Because the complex decomposes under an alkaline condition, the addition of NaOH was examined. To optimize the amount of NaOH, the eluent from the column was transferred into a cell, while changing the amount of NaOH added to the cell. The absorbance was measured as the complex concentration. When more than 0.1 ml of 4 mol l -1 NaOH was added to 10 ml of eluent, the absorbance of yellow-colored silicomolybdate disappeared, and a rapid decomposition of the complex was observed at that time. The same sample described above was analyzed with the addition of NaOH again, and the found silicon value was improved, to 20 µmol l -1 .
Tolerance levels of diverse salts
The tolerance levels of salts in a sample were examined by increasing the salt concentrations up to 10% at a constant amount of silicon (Fig. 3) . For all of the salts examined here, it was confirmed that up to 8% (w/w) was tolerable. It was also found that the results were sufficient for the analysis of blood, because the salt concentrations were lower in blood samples. 
Interference by phosphate, arsenate, germanate and other ions
Several ions interfere in the conventional silicomolybdenum blue method, 40, 41 and especially in the present method, phosphate, arsenate and germanate ions are expected to interfere, because they react with molybdate to form respective heteropolymolybdate complexes. At first, the silicon recoveries by the addition of various ions were examined, as shown in Table 1 . Except for germanate, the interference for all of the ions tested was not observed. As for germanate, the total amount of the original silicate and the additional germanate were found. Therefore, it was revealed that the existence of germanate caused a positive error. To obtain a further verification of those results, the elution curves of phosphate, arsenate and germanate ions were investigated. At first, the elution curve in the case of phosphate, made in the same way as silicate, is shown by curve 2 in Fig. 2 . As can be seen from the curve, the peak of the phosphomolybdate complex did not appear in the first 10 ml fraction. It can be understood that the complex dissociates into phosphate and molybdate through a rapid equilibrium 42 during the column treatment. This seems to indicate that the indirect method is free not only from the salt error, but also from the interference of phosphate. Similarly, it was confirmed that the arsenate ion showed a similar elution curve as phosphate, and was concluded not to interfere. On the other hand, since germanate ion showed the same type of elution curve as silicate, it seems to interfere due to a similar behavior of germanate to silicate. Concerning the germanium concentration in blood, there are presently a few reports, [43] [44] [45] and the reported germanium contents in healthy human blood samples have been unstable due to the limitation of the detection limit. However, it seems to be negligible in ordinary samples because the level of the germanium concentration is lower compared with that of silicon, except in the case of people who had occupational germanium exposure.
Sensitivity and precision
Three methods for the determination of molybdenum were tested to compare the sensitivity of the indirect method. A series of silicon standard solutions were analyzed by indirect methods using the BPR, FS and Tiron methods. For a comparison, they were also analyzed by the conventional silicomolybdenum blue (direct) method. As a result, the method using BPR showed the highest sensitivity, about fivefold better than the silicomolybdenum blue method, followed by the FS method, which was almost equal to that; the last was the Tiron method. The calibration curves of these indirect methods were linear up to 50 µmol l -1 for BPR, 50 µmol l -1 for FS and 10 µmol l -1 of silicon for Tiron method, respectively. Considering the results and the reason described below, it was found that the use of the FS method is appropriate for blood analysis. (1) In the FS method, the possible range of the determination is wide enough to analyze serum and whole blood by the same operation. (2) In the case of the BPR method, a small amount of organic residue, undecomposed even by the microwave digestion, tended to precipitate with the reagent using the BPR method. As for the FS method, such interference has never been observed.
The sensitivity of a indirect method employing the FS method was examined. The relative standard deviations were 0.6% (n = 5) for 20 µmol l -1 silicon solution, 0.9% and 1.8% (n = 5) for a 20 µmol l -1 silicon in serum and whole blood, respectively. The detection limits, defined as three-times the standard deviation of the blank, were 0.9, 0.4 and 1.1 µmol l -1 for deionized water, serum and whole blood, respectively. To check the recovery of the method, a known amount of silicon spiked in serum and whole blood were analyzed. As shown in Table 2 , the obtained recoveries of both samples were between 95 and 101%, which were satisfactory.
Determination of silicon in serum, whole blood, and erythrocytes
Human blood samples of five healthy subjects were analyzed by the proposed method. The results are listed in Table 3 . The estimated blood silicon concentrations of healthy subjects published by other researchers were in the range of 3 to 25 µmol l -1 for serum, [9] [10] [11] [12] 19, 20 and less than 180 µmol l -1 for whole blood. 17, 18, 20 Especially for whole blood, the number of publications is not very many, and the reported values have thus been uncertain among researchers. The results of this study were 9 -14 µmol l -1 for serum and 24 -32 µmol l -1 for whole blood, and were in good agreement with the range of values reported before. The silicon concentration in erythrocytes obtained from the values in serum and whole blood was 36 -60 µmol l -1 ; besides, the distribution ratio between serum and erythrocyte (Si,s/Si,e) was also obtained (Table 3) . From these results, it was revealed that the silicon concentration in whole blood distributes more than that in serum (Si,s/Si,e < 1), and that Si,s/Si,e ranged from 0.15 to 0.39, which showed the tendency to be included in a narrow range. Because the method is superior in precision and accuracy, the variety among respective Si,s/Si,e values seems to arise from the characteristics of individuals.
Conclusions
The proposed indirect method for the determination of silicon is free from the influence caused by a large amount, and complicated compositions of matrices in blood samples. Therefore, the precision and accuracy of analysis for biological samples was significantly improved. Since the method is usefully applicable for both serum and whole blood samples, it enabled us to perform the fractional determination of blood samples. The method is expected to contribute to a further clarification of the detailed distribution and the roles of silicon in blood. 
